Normothermic blood cardioplegia reperfusion plus nifedipine after cardioplegic arrest: experimental study with a new delivery set

Abstract

During the aortic crossclamping and the early period of reperfusion, the calcium metabolism plays an important role in myocardial ischaemic damage. In this study, we test the use of a calcium entry blocker (nifedipine) during the early reperfusion period after cardioplegic arrest. The experimental protocol was tested on 20 large white pigs weighing 28 ± 1 kg. All animals underwent hypothermic (28°C) cardiopulmonary bypass (CPB) and St Thomas II cold (4°C) cardioplegia was infused in a single dose (40 ml/kg of body weight) through the aortic root after aortic crossclamping (90 minutes). The animals were divided into four groups (five animals for each group): Group I-standard reperfusion after clamping the aorta; Group II-the same as Group I plus nifedipine 100 mg bolus in aortic root just prior to unclamping the aorta; Group III-reperfusion was done with warm (37°C) oxygenated blood cardioplegia via aortic root (flow rate 70 ml/min/100 gm of heart weight, St Thomas I I solution with haematocrit of 1 5% for five minutes); Group IV-the same as Group III, plus nifedipine in bolus (100 nmg) injected in aortic root prior to the cardioplegic blood reperfusion. In Groups III and IV reperfusion was performed with a new delivery set (Dideco D51 5) which allows cold crystallaoid cardioplegia to be poured into warm blood cardioplegia. Full thickness myocardial biopsies were taken before, during (90') and after (3', 5', 10' of reperfusion) the aortic crossclamping and the level of high energy phosphate (H EP) of ATP, CP, lactate and myocardial water content were measured. Global left ventricular function was evaluated measuring left atrial pressure (LAP) at constant cardiac output with a right heart preparation before cardioplegic arrest and after 30 minutes of reperfusion. The results show significant differences during reperfusion between the four groups as follows: (a) higher ATP recovery in Groups III and IV than in Groups I and II; (b) CP levels increased more significantly in Group IV than in the other groups; (c) lactate was lower in Groups I I I and IV; (d) myocardial water content increased significantly in Group I; (e) global left ventricular function showed that the heart of the animals of Groups III and IV could pump from 3-3.5 I/min. with a left atrial pressure of less than 20 mmHg in respect to the other two groups. We conclude that after prolonged aortic crossclamping, the reperfusion with warm oxygenated cardioplegic blood plus nifedipine provides better myocardial protection.

Get full access to this article

View all access options for this article.

References

Kirklin JW , Conti VR , Blackstone EH Prevention of myocardial damage during cardiac operations. N Engl J Med 1979; 301: 135-41.

Engelman RM , Spencer FC , Boyd AD , Chandra R. The significance of coronary arterial stenosis during cardiopulmonary bypass . J. Thorac Cardiovasc Surg, 1975; 70: 869-79.

Hilton CJ , Teubl W. , Acker M. , et al. Inadequate cardioplegic protection with obstructed coronary arteries. Ann Thorac Surg 1979; 28: 323-34.

Heineman FW , MacGregor DC , Wilson GJ , Ninomiya J. Regional and transmural myocardial temperature distribution in cold chemical cardioplegia. Significance of critical coronary arterial stenosis . J Thorac Cardiovasc Surg 1981; 81: 851-59.

Chitwood WR Jr , Sink JD , Hill RC , Wechsler AS , Sabiston DC Jr. The effects of hypothermia on myocardial oxygen consumption and transmural coronary blood flow in the potassium-arrested heart. Ann Surg 1979; 190: 106-16.

Gay WA Jr , Ebert PA Functional, metabolic, and morphologic effects of potassium-induced cardioplegia. Surgery 1973; 74: 284-90.

Hearse DJ , Stewart DA , Chain EB Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequence of various cardioplegic procedures in the isolated rat heart. Circ Res 1974; 35: 448-57.

Buckberg GD A proposed 'solution' to the cardioplegic controversy. J. Thorac Cardiovasc Surg 1979; 77: 803-15.

Dorsey LM , Colgan TK , Silverstein JI , Hatcher CRJr , Guyton RA Alterations in regional myocardial function after heterogeneous cardioplegia . J Thorac Cardiovasc Surg 1983; 86: 70-79.

10.

Ochsner JL Adequacy of myocardial protection. Ann Thorac Surg 1979; 28; 305-306.

11.

Drop LJ , Geffin GA , O'Keffe DD et al. Relation between ionized calcium concentration and ventricular pump performance in the dog under hemodynamically controlled conditions. Am J Cardiol 1981; 47: 1041-51.

12.

Bixler TJ , Flaherty JT , Gardner TJ , Bulkley BH , Schaff HV , Gott VL Effects of calcium administration during post-ischemic reperfusion on myocardial contractility, stiffness, edema and ultrastructure. Circulation 1978; 58 (Suppl 1): 184-94.

13.

Pirzada FA , Ekong EA , Vokonas PS , Apstein CS , Hood WB Experimental myocardial infarction. XIII. Sequential changes in left ventricular pressure-length relationships in the acute phase. Circulation 1976; 53: 970-75.

14.

Jennings RB , Sommers HM , Kaltenbach JP , West JJ Electrolyte alterations in acute myocardial ischemic injury. Circ Res 1964; 14: 260-69.

15.

Jennings RB , Ganote CE : Structural changes in myocardium during acute ischaemia. Circ Res 1973; 34 (Suppl 3): 156-68.

16.

Clark RE , Christlieb IY , Spratt JA , Henry PD , Fischer AE , Williamson JR Myocardial preservation with nifedipine. A comparative study at normothermia . Ann Thorac Surg 1981; 31: 3-19.

17.

Clark RE , Christlieb IY , Ferguson TB et al. The first American clinical trial of nifedipine in cardioplegia. A report of the first 12 month experience. J Thorac Cardiovasc Surg 1981; 82: 848-59.

18.

Henry PD , Shuchleib R. , Borda LJ , Roberts R. , Williamson JR , Sobel BE Effects of nifedipine on myocardial perfusion and ischaemic injury in dogs . Circ Res 1978; 43: 372.

19.

Selwyn AP , Welman E. , Fox K. , Horlock P. , Pratt T. , Klein M. The effects of nifedipine on acute experimental myocardial ischaemia and infarction in dogs. Circ Res 1979; 44: 16.

20.

McGovern GJ , Dixon CM , Burkholder JA Improved myocardial protection with nifedipine and potassium-based cardioplegia. J Thorac Cardiovasc Surg 1981; 82: 239-44.

21.

Clark RE , Christlieb IY , Henry PD et al. Nifedipine. A myocardial protective agent. Am J Cardiol 1979; 44: 825-31

22.

Vouhé PR , Helias J. , Grondin CM Myocardial protection through cold cardioplegia using diltiazem, a calcium channel blocker. Ann Thorac Surg 1980 ; 30: 342-48.

23.

Nayler WG , Ferrari R. , Williams A. : Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochrondrial function in the ischaemic and reperfused myocardium. Am J Cardiol 1980; 46: 242-48.

24.

Guyton RA , Dorsey Lma , Craver JM et al. Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution. J Thorac Cardiovasc Surg 1985; 89: 877-87.

25.

Ludin A. , Rickardson A. , Thore A. Continuous monitoring of ATP converting reactions by purified firefly luciferase . Ann Biochem 1976; 75: 611-20.

26.

Gutmann I. , Wahlefeld AW Lactate determination with lactate dehydrogenase and NAD. Methods of enzymatic analysis. New York. Academic Press , 1974.

27.

Cunningham JNJr , Adams PX , Knopp EA et al. Preservation of ATP, ultrastructure, and ventricular function after aortic crossclamping and reperfusion. J Thorac Cardiovasc Surg 1979; 78: 708-20.

28.

Takamoto S. , Levine FH , LaRaia PJ et al., Comparison of single-dose and multiple-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion. J. Thorac Cardiovasc Surg 1980; 79: 19-28.

29.

Lee BY , Wilson GJ , Domenech RJ , McGregor DC. Relative roles of edema versus contracture in the myocardial 'no-reflow' phenomenon. J. Surg Res 1980; 29: 50-61.

30.

Martin DR , Scott DF , Downes GL , Belzer FO Primary cause of unsuccessful liver and heart preservation: cold sensitivity of ATP-ase system. Ann Surg 1972; 175: 111-17.

31.

Engelman RM , Rousou JH , Dobbs W. , Pels MA , Longo F. The superiority of blood cardioplegia in myocardial preservation. Circulation 1980; 62 (Suppl 1): 62-66.

32.

Hearse DJ Reperfusion of ischaemic myocardium. J Moll Cell Cardiol 1977; 9: 607-16.

33.

West PN , Williamson JR , Nora JD et al. Reperfusion of ischaemic myocardium: Microvascular injury. Surg. Forum 1979; 28: 246-47.

34.

McDonagh PF , Laks H. Use of cold blood cardioplegia to protect against coronary microcirculatory injury due to ischemia and reperfusion. J Thorac Cardiovasc Surg 1982; 84: 609-18.

35.

Shen AC , Jennings RB Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972; 67: 417-40.

36.

Shen AC , Jennings RB Kinetics of calcium accumulation in acute myocardial ischemic injury . Am J Pathol 1972; 67: 441-52.

37.

Lang TW , Corday E. , Gold H. et al. Consequence of reperfusion after coronary occlusion: effect on hemodynamic and regional myocardial metabolic function. Am J Cardiol 1974; 33: 69-81.